Replay available

ABINGDON HEALTH PLC (ABDX) — Preliminary results for the year ended 30 June 2025

Preliminary results for the year ended 30 June 2025 hosted by ABINGDON HEALTH PLC (LSE: ABDX) on Investor Meet Company, held 2025-11-11.

Tue, November 11, 2025 at 6:00 AMendedReplay
ABINGDON HEALTH PLC (ABDX) — Preliminary results for the year ended 30 June 2025

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Tom Hayes

CFO at ABINGDON HEALTH PLC

Chris Hand

Chairman at ABINGDON HEALTH PLC

Replay transcript excerpt

Good morning, ladies and gentlemen. Welcome to the ABDON HEALTH PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged. They can be submitted at any time via the Q and A tab that's just situated on the right hand corner of your screen. Please simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and will publish your responses where it's appropriate to do so on the Investor Meet company platform. Before we begin, we would decide to hold a two minute silence for Remembrance Day. Thank you. I would now like to hand you over to the executive management team from ABDON HEALTH PLC, Chris. Good morning, sir. Good morning, Jake. Thank you. We'll just get the slide deck up. Yep. K. Good morning, everyone. Thanks for joining the results presentation for our financial year ending June 30. I'm Chris Hand. I'm the executive chairman of ABINGDON, and I'm joined by Tom Hayes, the chief financial officer. I'll hand over to Tom for the first few slides, which will give you a financial update on the company's progress. Thank you, Chris. Okay. So the the first slide in the presentation is a summary of the results for financial year ended June 25, which were released this morning. So I think the the key message on this side is that firstly that the these results were in in line with focus forecast that were were in the in the market, both at revenue and adjusted EBITDA level. I think the the second the second point I draw out is that really the you know, there was a quite a difference between h one and h two trading. So in in h one, we we saw some delays in de...

More from Abingdon Health Plc